Patent ID: 9095515
Filing Date: 2015-08-04
Classification: A61K

Abstract:
1. A pharmaceutical composition comprising (a). micronized ezetimibe or a pharmaceutically acceptable salt thereof being in the form of particles having a median particle size of less than or equal to 2 μm, (b). polyvinylpyrrolydone wherein micronized ezetimibe is finely distributed within the weight ratio of micronized ezetimibe to polyvinylpyrrolydone in the range of between 5:1 to 1:1 (w/w), and (c). sodium stearyl fumarate and colloidal silicon dioxide wherein the weight ratio of sodium stearyl fumarate to colloidal silicon dioxide is in the range of between 7:1 to 1:1 (w/w), and wherein said composition is free of magnesium stearate.